Skip to main content

Casdin Partners GP, LLC's Form 4 filing

Standard Biotools Inc.LAB · filed Mar 4, 2025

Accession no.
0000919574-25-001777
Filed
Mar 4, 2025, 8:19 PM ET
Trade date
Feb 28, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions. Open-market purchases total $5.13M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Casdin Partners GP, LLCCIK 0001534260Director, 10% Owner
Casdin Capital, LLCCIK 0001534261Director, 10% Owner
Casdin EliCIK 0001534264Director, 10% Owner
Casdin Partners Master Fund, L.P.CIK 0001534265Director, 10% Owner
Casdin Private Growth Equity Fund, L.P.CIK 0001823061Director
Casdin Private Growth Equity Fund GP, LLCCIK 0001864554Director
Casdin Private Growth Equity Fund II, L.P.CIK 0001891102Director
Casdin Private Growth Equity Fund II GP, LLCCIK 0001919480Director
Casdin Amplify Fund, LPCIK 000202825410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 28, 2025Common StockPPurchaseAcquired+4,820,959$1.07+$5,134,321.3458,846,780Indirect
Feb 28, 2025Common StockJOtherAcquired+545,000$1.07+$580,42559,391,780Indirect
Feb 28, 2025Common StockJOtherDisposed−545,000$1.07−$580,4250Indirect
Feb 28, 2025Common StockAGrant or awardAcquired+58,215$1.07F5+$61,998.982,806,470Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F5

The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $62,000 in cash compensation for services as a board member.

Referenced by the price of 1 transaction in Table I.

Remarks

Eli Casdin has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Casdin's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read the full filing on SEC EDGAR (opens in a new tab)